Effects of the support system combined with Chinese medicine on postoperative gastrointestinal recovery in patients with liver cancer

Table 1 Comparison of gastrointestinal recovery between the two groups, mean ± SD

Group	Cases	Bowel sound recovery time (hours)	First flatus time (hours)	First defecation time (hours)
Observation	49	44.69 ± 4.05	51.23 ± 5.05	72.05 ± 6.78
Control	49	49.87 ± 4.11	61.78 ± 5.11	75.52 ± 6.44
t	-	6.284	10.279	2.598
P value	-	< 0.001	< 0.001	0.011

Table 2 Comparison of liver function between the two groups, mean ± SD

Group	Cases	ALT (U/L)		AST (U/L)		TB (μmol/L)		GTT (U/L)		ALB (ng/mL)
		Before	After	Before	After	Before	After	Before	After	Before	After
Observation	49	55.14 ± 2.36	42.08 ± 2.06	76.87 ± 5.22	43.14 ± 3.06	44.25 ± 2.66	22.08 ± 2.14	182.56 ± 8.58	71.55 ± 5.06	29.75 ± 2.55	37.56 ± 3.05
Control	49	55.37 ± 2.44	45.78 ± 2.11	76.29 ± 5.40	46.78 ± 3.22	44.26 ± 2.78	26.55 ± 2.30	182.43 ± 8.14	76.98 ± 5.23	29.34 ± 2.40	34.66 ± 3.48
t	-	0.474	8.783	0.541	5.736	0.018	9.960	0.077	5.223	0.820	4.387
P value	-	0.636	< 0.001	0.590	< 0.001	0.986	< 0.001	0.939	< 0.001	0.414	< 0.001

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TB: Total bilirubin; GTT: Glutamyl transpeptidase; ALB: Albumin.

Table 3 Comparison of tumor marker levels between the two groups, mean ± SD

Group	Cases	CEA (ng/mL)		TK1 (μg/L)		AFP (ng/mL)		CA19-9 (U/mL)
		Before	After	Before	After	Before	After	Before	After
Observation	49	17.25 ± 1.56	6.53 ± 0.88	2.77 ± 0.32	1.61 ± 0.36	15.44 ± 1.55	7.58 ± 0.86	46.57 ± 4.05	33.69 ± 3.06
Control	49	17.43 ± 1.22	7.26 ± 0.74	2.68 ± 0.80	1.89 ± 0.40	15.29 ± 1.40	8.99 ± 0.87	46.43 ± 4.22	36.78 ± 3.28
t	-	0.636	4.444	0.731	3.642	0.503	8.068	0.168	4.822
P value	-	0.526	< 0.001	0.466	< 0.001	0.616	<0.001	0.867	< 0.001

CEA: Carcinoembryonic antigen; TK1: Thymidine kinase 1; AFP: Alpha-fetoprotein; CA19-9: Carbohydrate antigen 19-9.

Table 4 Comparison of immune function between the two groups, mean ± SD

Group	Cases	CD4+ (%)		CD8+ (%)
		Before	After	Before	After
Observation	49	25.43 ± 1.66	28.98 ± 1.15	37.56 ± 1.26	31.25 ± 1.02
Control	49	25.38 ± 1.40	27.16 ± 1.44	37.29 ± 1.33	33.77 ± 1.20
t	-	0.161	6.913	1.032	11.201
P value	-	0.872	< 0.001	0.305	< 0.001

Table 5 Comparison of the two groups, n (%)

Group	Cases	Allergic reaction	Bleeding	Rash	Abdominal pain	Total incidence
Observation	49	1 (2.04)	1 (2.04)	1 (2.04)	2 (4.08)	5 (10.20)
Control	49	1 (2.04)	0 (0.00)	0 (0.00)	1 (2.04)	2 (4.08)
χ2	-	-	-	-	-	0.615
P value	-	-	-	-	-	0.433